Net Income (Loss) Attributable to Parent in USD of Dyne Therapeutics, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Dyne Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q3 2025.
  • Dyne Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$108M, a 11.2% decline year-over-year.
  • Dyne Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$424M, a 43.9% decline year-over-year.
  • Dyne Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$317M, a 34.5% decline from 2023.
  • Dyne Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$236M, a 40.4% decline from 2022.
  • Dyne Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$168M, a 12.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Dyne Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$424M -$108M -$10.9M -11.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 -$413M -$111M -$45.8M -70.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-05
Q1 2025 -$367M -$115M -$49.7M -75.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-05
Q4 2024 -$317M -$89.5M -$22.9M -34.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$295M -$97.1M -$36.9M -61.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 -$258M -$65.1M -$200K -0.31% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-05
Q1 2024 -$257M -$65.6M -$21.5M -48.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-05
Q4 2023 -$236M -$66.6M -$27.8M -71.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$208M -$60.2M -$18.8M -45.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$189M -$64.9M -$12.6M -24.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$177M -$44.2M -$8.6M -24.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$168M -$38.8M +$13M +25% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$181M -$41.4M +$1.2M +2.81% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-30
Q2 2022 -$182M -$52.3M -$22.3M -74.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-30
Q1 2022 -$160M -$35.6M -$10.6M -42.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-10-30
Q4 2021 -$149M -$51.8M -$23.1M -80.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$126M -$42.6M -$28.7M -206% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$97.5M -$30M -$21M -234% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$76.5M -$25M -$17.1M -217% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$59.4M -$28.6M -$23.2M -430% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$36.2M -$13.9M -$8.05M -137% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$28.1M -$8.98M -$7.49M -500% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$20.7M -$7.89M -$5.8M -278% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$14.9M -$5.4M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$5.87M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$1.5M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$2.09M Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05

Dyne Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$317M -$81.5M -34.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$236M -$67.8M -40.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$168M -$18.8M -12.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$149M -$89.9M -151% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 -$59.4M -$44.6M -300% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$14.9M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.